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FIRST CLINICAL CASE REPORTFirst case of isolation of Nocardia wallacei reported in MexicoJ. González-Nava1, K. Sánchez-Herrera1, N. Ramírez-Durán2 and H. Sandoval1
1) Universidad Autónoma Metropolitana Unidad Xochimilco, Mexico City and 2) Facultad de Medicina, Universidad Autónoma del Estado de México, Toluca,
MexicoAbstractNocardia species are aerobic, Gram-positive bacteria with branched ﬁlaments reported as opportunistic microorganisms associated with
infectious diseases of the skin. We report the isolation of N. wallacei in Mexico from a 43-year-old man, an HIV-positive construction
worker who sought care for difﬁculty breathing and abundant sputum.
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E-mail: hsandov@correo.xoc.uam.mxIntroductionNocardia species are ubiquitous in the environment as sapro-
phytic bacteria. The Nocardia genus comprises aerobic, Gram
positive and branched bacteria that have the potential to cause
localized or disseminated infection [1]. A major risk factor for
Nocardia infection is being immunocompromised, speciﬁcally
those with cell-mediated immunity defects, including HIV [2].
Although the incidence and prevalence of the disease are not
known, a 2013 study showed that of 8763 cases reported since
1956, 30% (2607 cases) occurred in Mexico, 29% (2555 cases)
in Sudan and 16% (1392 cases) in India. However, there are data
that strongly suggest that the real disease burden is probably
more important than indicated in a meta-analysis by the In-
ternational Society for Neglected Tropical Diseases (http://
www.isntd.org/isntd-disease-briefs/4592435414). The majority
of nocardiosis cases are caused by the N. asteroides complex
and N. brasiliensis [3]. This is the ﬁrst report of isolation of
N. wallacei in a man with HIV/AIDS and pulmonary failure in
Mexico.© 2016 The Author(s). Published by El
This is an oMaterials and MethodsOrganism
The strain was obtained from General Hospital “Dr Manuel
Gea González” and was identiﬁed as Nocardia sp. The patient
was a 43-year-old man, an HIV-positive construction worker
who sought care for difﬁculty breathing and abundant sputum.
The strain was grown at 37°C in brain–heart infusion medium
(Bioxon, Becton Dickinson, México) for 7 days, and it was
coded as strain Mic-SIDA.
Phenotype identiﬁcation
Colony morphology and Gram stain were determinate; 13 tests
of acid production from several substrates and antibiotic
sensitivity were performed (Table 1). The comparison of the
Mic-SIDA strain was made using biochemical tests of N. wallacei
(ATCC (American Type Culture Collection, Manassas, VA,
USA) 49873T) against a clinical isolated strain of N. wallacei and
N. transvalensis (ATCC 6865T) strain [4].
Gene sequencing
DNA extractions were performed by the Wizard kit following
the manufacturer’s instructions (Promega, Madison, WI, USA).
Ampliﬁcation of the 16S rRNA sequence was carried out using
the PCR method. The primers used were 8F: 50-AGAGTTT-
GATCMTGGCTCAG-30 and 1492R: 50-TACGGY-
TACCTTGTTACGACTT-30 [5].New Microbe and New Infect 2016; 14: 83–84
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TABLE 1. Comparison of biochemical tests and antibiotic
sensitivity between strain Mic-SIDA and reference strainsa
Test and
sensitivity
Mic-SIDA
strain
Nocardia
transvalensis
ATCC 6865T
Nocardia
wallacei
ATCC
49873T
Nocardia
wallacei
clinical
isolate
Biochemical test
Arabinose − − − −
Lactose − − − −
Mannose − − − −
D-Sorbitol − + − −
Trehalose + + + +
D-Xylose − − − −
D-Mannitol − + − −
D-Glucose + + + +
D-Galactose + + + +
L-Rhamnose − − − −
Cellobiose − − − −
Esculin + + + +
Casein − − − −
Antibiotic sensitivity
Amikacin R R R
Ceftriaxone S S S
Trimethoprim-
sulfamethoxazole
S S/R S/R
ATCC, American Type Culture Collection (Manassas, VA, USA); R, resistant; S,
susceptible.
aData adapted from Conville et al. [4].
84 New Microbes and New Infections, Volume 14 Number C, November 2016 NMNIThe ampliﬁcation was performed using the MyTaq DNA
Polymerase (Bioline, USA) kit. The reaction parameters were as
follows: 30 cycles; predenaturation 5 minutes at 94°C; dena-
turation 60 seconds at 94°C; annealing 30 seconds at 59°C;
extension 60 seconds at 72°C; and ﬁnally extension post-
ampliﬁcation 10 minutes at 72°C. The products were
sequenced in the Macrogen Laboratory (Rockville, MD, USA)
and compared with the corresponding GenBank and NZ-Taxon
registered sequences [6].ResultsColonies were white, with a dusty appearance and irregular
borders. The strain was Gram positive, highly branched with
large ﬁlaments and further fragmentation to rods and cocco-
bacilli. The biochemical analysis indicated similarities with
N. wallacei type strain but not with N. transvalensis species
(Table 1).
The 16S rRNA gene sequencing (1354 bp) indicated a
99.17% homology towards N. wallacei (ATCC 49873T) in© 2016 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Micr
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4GenBank-BLAST (Basic Local Alignment Search Tool; National
Center for Biotechnology Information, Bethesda, MD) and
98.66% in NZ-Taxon; but the gene sequence had a 97.94% of
similarity to N. transvalensis (ATCC 6865T) in GenBank
(BLAST) and 97.82% in NZ-Taxon databases.DiscussionN. wallacei species is not well known and may cause rare in-
fections [7], so its identiﬁcation in a clinical setting can be
complicated; however, with joint analysis by biochemical and
molecular tests, it is possible identify accurately.Conﬂict of InterestNone declared.References[1] Brown-Elliott BA, Brown JM, Conville PS, Wallace Jr RJ. Clinical and
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